InfuSystem Holdings (INFU) Other Non Operating Income (2010 - 2026)
InfuSystem Holdings (INFU) posted Other Non Operating Income of $82000.0 for Q1 2026, up 90.7% on a QoQ basis from $43000.0 in Q4 2025, and up 382.76% year-over-year from $16985.7 in Q1 2025.
InfuSystem Holdings (INFU) Other Non Operating Income (2010 - 2026) Analysis & Trends
InfuSystem Holdings' Other Non Operating Income history runs 17 years deep, the most recent figure standing at $82000.0 for Q1 2026.
- Quarterly Other Non Operating Income rose 382.76% year-over-year to $82000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $113000.0 (up 229.89% YoY) and the FY2025 annual result came in at $2000.0, up 103.64% from the prior year.
- Other Non Operating Income was $82000.0 for Q1 2026 at InfuSystem Holdings, up from $43000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $82000.0 in Q1 2026 and bottomed at -$63000.0 in Q2 2024.
- A 5-year average of -$9411.8 and a median of -$14000.0 in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2024 — Other Non Operating Income slumped 3250.0% — and 2026, when it soared 382.76%.
- InfuSystem Holdings' Other Non Operating Income stood at -$53000.0 in 2022, then soared by 62.26% to -$20000.0 in 2023, then surged by 145.0% to $9000.0 in 2024, then soared by 377.78% to $43000.0 in 2025, then soared by 90.7% to $82000.0 in 2026.
- Business Quant data shows INFU's Other Non Operating Income at $82000.0 in Q1 2026, $43000.0 in Q4 2025, and -$54000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | InfuSystem Holdings | 179.47 Mn | 177.37 Mn | 19.68 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 82,000.00 |
| Dec 31, 2025 | 43,000.00 |
| Sep 30, 2025 | -54,000.00 |
| Jun 30, 2025 | 42,000.00 |
| Mar 31, 2025 | -29,000.00 |
| Dec 31, 2024 | 9,000.00 |
| Sep 30, 2024 | -4,000.00 |
| Jun 30, 2024 | -63,000.00 |
| Mar 31, 2024 | 3,000.00 |
| Dec 31, 2023 | -20,000.00 |
| Sep 30, 2023 | -14,000.00 |
| Jun 30, 2023 | 2,000.00 |
| Mar 31, 2023 | -35,000.00 |
| Dec 31, 2022 | -53,000.00 |
| Sep 30, 2022 | -11,000.00 |
| Jun 30, 2022 | -30,000.00 |
| Mar 31, 2022 | -28,000.00 |
| Dec 31, 2021 | -36,000.00 |
| Sep 30, 2021 | -44,000.00 |
| Jun 30, 2021 | -37,000.00 |